Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities

Detalhes bibliográficos
Autor(a) principal: Rocha, Leticia B.
Data de Publicação: 2012
Outros Autores: Luz, Daniela E., Moraes, Claudia T. P., Caravelli, Andressa, Fernandes, Irene, Guth, Beatriz Ernestina Cabilio [UNIFESP], Horton, Denise S. P. Q., Piazza, Roxane M. F.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/35200
http://dx.doi.org/10.3390/toxins4090729
Resumo: Monoclonal antibodies (MAbs) have been employed either for diagnosis or treatment of infections caused by different pathogens. Specifically for Shiga toxin-producing Escherichia coli (STEC), numerous immunoassays have been developed for STEC diagnosis, showing variability in sensitivity and specificity when evaluated by reference laboratories, and no therapy or vaccines are currently approved. Thus, the aim of this work was the characterization of the interaction between MAbs against Stx1 and Stx2 toxins and their neutralizing abilities to enable their use as tools for diagnosis and therapy. the selected clones designated 3E2 (anti-Stx1) and 2E11 (anti-Stx2) were classified as IgG1. 3E2 recognized the B subunit of Stx1 with an affinity constant of 2.5 x 10(-10) M, detected as little as 6.2 ng of Stx1 and was stable up to 50 degrees C. in contrast, 2E11 recognized the A subunit of Stx2, was stable up to 70 degrees C, had a high dissociation constant of 6.1 x 10(-10) M, and detected as little as 12.5 ng of Stx2. Neutralization tests showed that 160 ng of 3E2 MAb inhibited 80% of Stx1 activity and 500 mu g 2E11 MAb were required for 60% inhibition of Stx2 activity. These MAb amounts reversed 25 to 80% of the cytotoxicity triggered by different STEC isolates. in conclusion, these MAbs show suitable characteristics for their use in STEC diagnosis and encourage future studies to investigate their protective efficacy.
id UFSP_07583c0a022022622276479301a86a3a
oai_identifier_str oai:repositorio.unifesp.br:11600/35200
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Rocha, Leticia B.Luz, Daniela E.Moraes, Claudia T. P.Caravelli, AndressaFernandes, IreneGuth, Beatriz Ernestina Cabilio [UNIFESP]Horton, Denise S. P. Q.Piazza, Roxane M. F.Butantan InstUniversidade Federal de São Paulo (UNIFESP)2016-01-24T14:27:36Z2016-01-24T14:27:36Z2012-09-01Toxins. Basel: Mdpi Ag, v. 4, n. 9, p. 729-747, 2012.2072-6651http://repositorio.unifesp.br/handle/11600/35200http://dx.doi.org/10.3390/toxins4090729WOS000315405900007.pdf10.3390/toxins4090729WOS:000315405900007Monoclonal antibodies (MAbs) have been employed either for diagnosis or treatment of infections caused by different pathogens. Specifically for Shiga toxin-producing Escherichia coli (STEC), numerous immunoassays have been developed for STEC diagnosis, showing variability in sensitivity and specificity when evaluated by reference laboratories, and no therapy or vaccines are currently approved. Thus, the aim of this work was the characterization of the interaction between MAbs against Stx1 and Stx2 toxins and their neutralizing abilities to enable their use as tools for diagnosis and therapy. the selected clones designated 3E2 (anti-Stx1) and 2E11 (anti-Stx2) were classified as IgG1. 3E2 recognized the B subunit of Stx1 with an affinity constant of 2.5 x 10(-10) M, detected as little as 6.2 ng of Stx1 and was stable up to 50 degrees C. in contrast, 2E11 recognized the A subunit of Stx2, was stable up to 70 degrees C, had a high dissociation constant of 6.1 x 10(-10) M, and detected as little as 12.5 ng of Stx2. Neutralization tests showed that 160 ng of 3E2 MAb inhibited 80% of Stx1 activity and 500 mu g 2E11 MAb were required for 60% inhibition of Stx2 activity. These MAb amounts reversed 25 to 80% of the cytotoxicity triggered by different STEC isolates. in conclusion, these MAbs show suitable characteristics for their use in STEC diagnosis and encourage future studies to investigate their protective efficacy.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Butantan Inst, Bacteriol Lab, São Paulo, BrazilButantan Inst, Immunopathol Lab, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Microbiol, Escola Paulista Med, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Microbiol, Escola Paulista Med, São Paulo, BrazilWeb of Science729-747engMdpi AgToxinsStx1Stx2monoclonal antibodiesbindingstabilitydetectionneutralizing abilityspecificityInteraction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilitiesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALWOS000315405900007.pdfapplication/pdf1412043${dspace.ui.url}/bitstream/11600/35200/1/WOS000315405900007.pdf6e57a67bf8db649c0ce35f1778303f15MD51open accessTEXTWOS000315405900007.pdf.txtWOS000315405900007.pdf.txtExtracted texttext/plain51153${dspace.ui.url}/bitstream/11600/35200/2/WOS000315405900007.pdf.txtcb36f8b66705aa08e421d32c6737a682MD52open access11600/352002023-02-15 09:10:18.174open accessoai:repositorio.unifesp.br:11600/35200Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-05-25T12:30:36.470250Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities
title Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities
spellingShingle Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities
Rocha, Leticia B.
Stx1
Stx2
monoclonal antibodies
binding
stability
detection
neutralizing ability
specificity
title_short Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities
title_full Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities
title_fullStr Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities
title_full_unstemmed Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities
title_sort Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities
author Rocha, Leticia B.
author_facet Rocha, Leticia B.
Luz, Daniela E.
Moraes, Claudia T. P.
Caravelli, Andressa
Fernandes, Irene
Guth, Beatriz Ernestina Cabilio [UNIFESP]
Horton, Denise S. P. Q.
Piazza, Roxane M. F.
author_role author
author2 Luz, Daniela E.
Moraes, Claudia T. P.
Caravelli, Andressa
Fernandes, Irene
Guth, Beatriz Ernestina Cabilio [UNIFESP]
Horton, Denise S. P. Q.
Piazza, Roxane M. F.
author2_role author
author
author
author
author
author
author
dc.contributor.institution.none.fl_str_mv Butantan Inst
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Rocha, Leticia B.
Luz, Daniela E.
Moraes, Claudia T. P.
Caravelli, Andressa
Fernandes, Irene
Guth, Beatriz Ernestina Cabilio [UNIFESP]
Horton, Denise S. P. Q.
Piazza, Roxane M. F.
dc.subject.eng.fl_str_mv Stx1
Stx2
monoclonal antibodies
binding
stability
detection
neutralizing ability
specificity
topic Stx1
Stx2
monoclonal antibodies
binding
stability
detection
neutralizing ability
specificity
description Monoclonal antibodies (MAbs) have been employed either for diagnosis or treatment of infections caused by different pathogens. Specifically for Shiga toxin-producing Escherichia coli (STEC), numerous immunoassays have been developed for STEC diagnosis, showing variability in sensitivity and specificity when evaluated by reference laboratories, and no therapy or vaccines are currently approved. Thus, the aim of this work was the characterization of the interaction between MAbs against Stx1 and Stx2 toxins and their neutralizing abilities to enable their use as tools for diagnosis and therapy. the selected clones designated 3E2 (anti-Stx1) and 2E11 (anti-Stx2) were classified as IgG1. 3E2 recognized the B subunit of Stx1 with an affinity constant of 2.5 x 10(-10) M, detected as little as 6.2 ng of Stx1 and was stable up to 50 degrees C. in contrast, 2E11 recognized the A subunit of Stx2, was stable up to 70 degrees C, had a high dissociation constant of 6.1 x 10(-10) M, and detected as little as 12.5 ng of Stx2. Neutralization tests showed that 160 ng of 3E2 MAb inhibited 80% of Stx1 activity and 500 mu g 2E11 MAb were required for 60% inhibition of Stx2 activity. These MAb amounts reversed 25 to 80% of the cytotoxicity triggered by different STEC isolates. in conclusion, these MAbs show suitable characteristics for their use in STEC diagnosis and encourage future studies to investigate their protective efficacy.
publishDate 2012
dc.date.issued.fl_str_mv 2012-09-01
dc.date.accessioned.fl_str_mv 2016-01-24T14:27:36Z
dc.date.available.fl_str_mv 2016-01-24T14:27:36Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Toxins. Basel: Mdpi Ag, v. 4, n. 9, p. 729-747, 2012.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/35200
http://dx.doi.org/10.3390/toxins4090729
dc.identifier.issn.none.fl_str_mv 2072-6651
dc.identifier.file.none.fl_str_mv WOS000315405900007.pdf
dc.identifier.doi.none.fl_str_mv 10.3390/toxins4090729
dc.identifier.wos.none.fl_str_mv WOS:000315405900007
identifier_str_mv Toxins. Basel: Mdpi Ag, v. 4, n. 9, p. 729-747, 2012.
2072-6651
WOS000315405900007.pdf
10.3390/toxins4090729
WOS:000315405900007
url http://repositorio.unifesp.br/handle/11600/35200
http://dx.doi.org/10.3390/toxins4090729
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Toxins
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 729-747
dc.publisher.none.fl_str_mv Mdpi Ag
publisher.none.fl_str_mv Mdpi Ag
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/35200/1/WOS000315405900007.pdf
${dspace.ui.url}/bitstream/11600/35200/2/WOS000315405900007.pdf.txt
bitstream.checksum.fl_str_mv 6e57a67bf8db649c0ce35f1778303f15
cb36f8b66705aa08e421d32c6737a682
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1783460300578619392